Increased levels of NF-κB inhibitors (IκBα and IκBγ) in the intestinal mucosa of Crohn's disease patients during infliximab treatment, Guidi, L., Costanzo Mario, Ciarniello M., De Vitis I., Pioli Claudio, Gatta L., Pace L., Tricerri A., Bartoloni C., Coppola L., et al. , International Journal of Immunopathology and Pharmacology, Volume 18, Number 1, p.155-164, (2005)